Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 23 Genitourinary 9 Classical hematology 9 Other hematologic neoplasm 8 CNS 4 Thoracic 3 Lymphoid 3 Gynecologic 2 Endocrine 2 Sarcoma 1 Plasma cell 1 Myeloid 1

Conditions

Sarcoma 960 Glioblastoma 299 Gliosarcoma 288 Osteosarcoma 286 Brain Neoplasms 195 Dendritic Cell Sarcoma, Interdigitating 188 Gastrointestinal Stromal Tumors 180 Bone Neoplasms 172 Lymphoma 161 Central Nervous System Neoplasms 160 Astrocytoma 155 Sarcoma, Ewing 151 Glioma 149 Precursor Cell Lymphoblastic Leukemia-Lymphoma 147 Lymphoma, Non-Hodgkin 143 Burkitt Lymphoma 139 Neoplasms 137 Recurrence 134 Lymphoma, Large B-Cell, Diffuse 128 Lymphoma, Follicular 128 Rhabdomyosarcoma 126 Neuroblastoma 126 Hodgkin Disease 124 Oligodendroglioma 123 Breast Neoplasms 123 Lymphoma, Mantle-Cell 117 Leukemia, Myeloid, Acute 117 Leukemia, Lymphocytic, Chronic, B-Cell 117 Lymphoma, B-Cell, Marginal Zone 113 Leukemia 111

Interventions

Tranexamic Acid 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemorrhage × Sarcoma × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡